首页> 美国卫生研究院文献>Annals of the Rheumatic Diseases >Observational study on efficacy safety and drug survival of anakinra in rheumatoid arthritis patients in clinical practice

【2h】

Observational study on efficacy safety and drug survival of anakinra in rheumatoid arthritis patients in clinical practice

机译：类风湿关节炎患者anakinra疗效安全性和药物生存的临床观察研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundThe efficacy and safety of anakinra, a recombinant human interleukin 1 (IL1) receptor antagonist used in rheumatoid arthritis, has been documented in five randomised controlled studies. However, long term post‐marketing efficacy data are lacking.

机译：背景anakinra（一种用于类风湿性关节炎的重组人白介素1（IL1）受体拮抗剂）的疗效和安全性已在五项随机对照研究中得到了证明。但是，缺乏长期的上市后功效数据。

著录项

期刊名称 Annals of the Rheumatic Diseases
作者
A A den Broeder; E de Jong; M J A M Franssen; M E C Jeurissen; M Flendrie; F H J van den Hoogen;
展开▼
作者单位

展开▼
年(卷),期 2006(65),6
年度 2006
页码 760–762
总页数 3
原文格式 PDF
正文语种
中图分类免疫性疾病;
关键词
anakinra rheumatoid arthritis drug survival;

机译：anakinra;类风湿关节炎;药物存活;

相似文献

外文文献
中文文献
专利

1. Safety and efficacy of tocilizumab as monotherapy or in combination with methotrexate in Tunisian patients with active rheumatoid arthritis and inadequate response to disease-modifying anti-rheumatic drugs in conditions close to clinical practice [J] . Clinical rheumatology . 2020,第5期

机译：Tocilizumab作为单药治疗或与突尼斯患者中甲氨蝶呤组合的安全性和有效性，具有活跃的类风湿性关节炎，在接近临床实践的条件下对疾病改性抗风湿药物的反应不足
2. Efficacy of rituximab in patients with rheumatoid arthritis refractory or with contra-indication to anti-tumor necrosis factor-alpha drugs in daily practice: an open label observational study [J] . A. Kahan, L. Gossec, M. Dougados, Clinical and experimental rheumatology . 2007,第3期

机译：利妥昔单抗在类风湿性关节炎难治性患者或日常实践中禁忌抗肿瘤坏死因子-α药物的功效：一项开放性观察研究
3. Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project [J] . Kylie Thaler, Divya V Chandiramani, Richard A Hansen, Biologics: Targets and Therapy . 2009,第1期

机译：anakinra治疗类风湿关节炎的功效和安全性：俄勒冈州药物疗效评估项目的更新
4. Deep radiomic prediction with clinical predictors of the survival in patients with rheumatoid arthritis-associated interstitial lung diseases [C] . Radin A. Nasirudin, Janne J. Nappi, Chinatsu Watari, SPIE Medical Imaging Conference . 2018

机译：类风湿关节炎相关性间质性肺疾病患者的深部放射学预测和生存期的临床预测
5. Clinical research on the preventive efficacy of sulfasalazine against Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis [D] . 布川貴博 2019

机译：柳氮磺胺吡啶对类风湿关节炎肺炎克氏杆菌的预防作用的临床研究
6. Efficacy and safety of anakinra for the treatment of rheumatoid arthritis: an update of the Oregon Drug Effectiveness Review Project [O] . Kylie Thaler, Divya V Chandiramani, Richard A Hansen, 2009

机译：Anakinra治疗类风湿关节炎的功效和安全性：俄勒冈州药物疗效评估项目的更新
7. Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice [O] . den Broeder, A A, de Jong, E, Franssen, M J A M, 2006

机译：类风湿关节炎患者anakinra疗效，安全性和药物生存的临床观察研究

Observational study on efficacy safety and drug survival of anakinra in rheumatoid arthritis patients in clinical practice

摘要

著录项

相似文献

相关主题

期刊订阅